UK: Types Of Intellectual Property Protection For Inventions And Granting Procedure

'The basics of patent law' covers key information relating to patent law, including: Types of intellectual property protection for inventions and granting procedure; Initiating proceedings; Infringement and related actions; Validity challenges, revocation actions and other procedures to remove the effect of an IP right; Trial, appeal and settlement; Remedies and costs; Assignment and licensing and the Unified Patent Court and Unitary Patent system.

The articles underpin Gowling WLG's contribution to Chambers' Global Practice Guide on Patent Litigation 2017, for which Gordon Harris and Ailsa Carter wrote the UK chapter.

Introduction

In the United Kingdom, inventions may be protected pursuant the patent system. In addition, for information with the necessary quality of confidence, the tort of breach of confidence may assist in protecting against unauthorised use.

Supplementary Protection Certificates (SPCs) enable a limited extension of patent term in respect of pharmaceutical or plant protection products in qualifying circumstances.

The grant of a patent covering the UK

In basic terms, there are two systems pursuant to which a patent may be granted covering the UK: the national system and the European system. Either system may be preceded by, or may provide the receiving office for, an application under the international system.

National patent system

Under the national system, an application is made to the UK Intellectual Property Office (UKIPO), for a 'GB' patent which covers the UK. The grant of a GB patent is governed by the UK Patents Act 1977 (the "Patents Act" or "PA") and associated legislation, with details of procedures set out in the Patents Rules 2007 (as amended) and the Manual of Patent Practice ("MPP") and guidance notes.

Any natural or legal person may apply for a patent in the UK, either alone or jointly with another, provided they are the inventor(s) or otherwise entitled to the property in it (PA s.7). The first step in the procedure for obtaining a patent is to file an application (which may declare a priority filing), thereby obtaining a date of filing. The patent application includes a written description of the invention, drawings if referred to, and (optionally at filing, failing which within 12 months) claims and an abstract. Preliminary examination, search, publication, substantive examination, grant and publication follow, assuming procedural and substantive requirements are met and the requisite fees paid. The term of patent protection is 20 years from the date of filing the application, provided renewal fees are paid.

It is possible for third parties to make observations in writing to the Comptroller-General of Patents, Designs and Trade Marks (the "Comptroller") about the patentability of a published application before grant (PA s.21). The UKIPO recommends that any observations be filed within three months of the publication of the application, as a patent may be granted after this period. The observations must be duly considered and in the usual course a copy of them must be provided to the applicant. A person does not become a party to any proceedings by making observations.

Appeal against a refusal by the UKIPO to grant a national patent lies to the Patents Court (a specialist list within the Chancery Division of the High Court of England and Wales) or, where applicable, Scotland's Court of Session (PA s.97).

It is permissible to apply for a national patent without using a professional representative but this is not recommended. The application process usually takes approximately three to five years from the date of filing the application, but can be considerably quicker than this if some fees are paid early and correspondence from the UK is responded to promptly.

For processing the application through to grant, UKIPO fees are usually in the region £230-300. Additional costs may be incurred by the applicant in professional services for drafting, translation and representation. These will vary greatly in accordance with the relevant circumstances.

European patent system

The European patent system (including the European Patent Office (EPO)) was established by the European Patent Convention 1973 (EPC), an international treaty made outside the remit of the European Union. It provides for the centralised application, prosecution and grant of patents (as a bundle of national designations) in and by the EPO. Aside from the EPO's remit to hear post-grant oppositions filed within the first nine months of grant, and centralised applications by the proprietor for amendment or revocation, questions of infringement and validity of each national designation are at present a matter for the courts of each relevant country.

For the grant of a patent covering the UK under the European patent system, an application is made to the EPO for a European Patent designating the UK (an 'EP(UK)'). The grant procedure (for all specified country designations) is governed by the EPC, with additional and more detailed provisions set out in the Implementing Regulations, the Rules Relating to Fees and the Guidelines for Examination in the European Patent Office.

Any natural or legal person(s) may file an application for a European patent, provided they are the inventor(s) or successor(s) in title (EPC Arts. 58 & 60). This may be the employer(s) of the inventor(s), where applicable under the law of the relevant contracting state, and an application may be filed by joint applicants. The first step in the procedure is to file an application (which may declare a priority filing), thereby obtaining a date of filing. The application must include a request for the grant of a European patent and a description and drawings (if any). Claims and an abstract must also be provided. Formalities examination, publication, search (and publication), substantive examination (by the EPO's Examining Division), and grant and publication follow, provided substantive requirements are met and the relevant fees are paid.

Following publication of the European patent application, any person may present observations concerning the patentability of the invention, which must be filed in writing in English, French or German (EPC Art.115, Implementing Rule 114). The observations are communicated to the applicant or proprietor and he may comment on them. If they call into question the patentability of the invention in whole or in part, they must be taken into account in any proceedings pending before a department of the EPO until such proceedings have been terminated. Observations will also be made available for inspection upon the start of any opposition proceedings (on which please see below).

Within nine months of grant, any person may file a written opposition to the grant of the European patent at the EPO, on one of the prescribed grounds (lack of patentability, insufficiency, added matter) (EPC Arts. 99-100). The parties' submissions in the inter partes opposition procedure are considered and decided upon by the EPO's Opposition Division, with appeal lying to a Board of Appeal. Where the opposition succeeds, or leads to the amendment of the patent, it is revoked or amended in respect of all designations for which it was granted. The EPO's decision can therefore have the effect of over-riding any amendments meanwhile made to the national designation(s) pursuant to national law and procedure.

The EPC provides also for a post-grant limitation and revocation procedure whereby the proprietor may make a central application to amend the claims of a granted patent or to revoke them. Again, the decision applies in respect of all designations for which the European patent was granted.

Appeal can be filed against a decision of a first instance division of the EPO to the EPO's Boards of Appeal. The relevant Board then acts as the department of final instance in the relevant procedure before the EPO. Reference to the Enlarged Board of Appeal is limited, essentially, to points of law and is rare.

Natural and legal applicants having either their residence or their principal place of business in a contracting state to the EPC can themselves undertake all procedural steps before the EPO and are not obliged to appoint a representative. Other applicants are, however, required to be represented by a professional representative or a legal practitioner. An association of professional representatives can also be authorised.

The process for grant of a European patent typically takes approximately three to eight years, but it can be quicker or slower than this, and opposition may lengthen the duration of EPO proceedings.

The filing and search fees due at the beginning of the application procedure for a European patent currently amount to approximately EUR 1,500, with remaining fees payable later. In total, it costs on average approximately EUR 6,000 in fees to take a patent application through to the grant stage. Additional costs may be incurred by the applicant in professional services for drafting, translation and representation, but these will vary greatly in accordance with the relevant circumstances.

At the post-grant stage, competence is transferred to the contracting states designated in the European patent. Validation procedures (which may include translations and payment of fees) must be completed in each country of interest within three months of grant. The granted European patent will only take effect in countries where it is validated. However, for the UK, pursuant to the London Agreement the translation requirements of Article 65(1) EPC have been dispensed with.

After the end of the year of grant or, if it is granted before the end of the fourth year of its term, after the end of that fourth year, annual renewal fees are payable to the UK Office in order to maintain the UK designation of a European patent (EPC Art. 86, Implementing Rules 37(4) & 38(1), PA s.77, MPP). For more on fees, please see below.

International application system

National patents and European patents covering the UK may alternatively be designated as part of a Patent Cooperation Treaty (PCT) application (an 'international application').

The international application system enables some consolidation of patent applications made internationally. The central coordination of the system is conducted by the World Intellectual Property Office (WIPO) in Geneva at the 'International Bureau'.

The filing of an international application, designating contracting states and regions for which the application is made, begins the 'international phase' of the application, in which the application will ultimately be searched against the prior art by an International Searching Authority (ISA). The purpose of the search is to discover relevant prior art. The search report and the ISA's written opinion are transmitted to the applicant and the International Bureau. The applicant may request supplemental searches. The international application is published 18 months after the claimed priority date. Applicants may optionally request substantive examination, although the resulting opinion is non-binding on national and regional offices.

If the application reaches the 'national' or 'regional' phase, then the countries (or regions) in respect of which it has entered that phase will proceed with examination.

Any resident or national of a contracting state to the PCT may file an international application. The UKIPO can act as a receiving office for an international patent application where the applicant (or one of them) is resident in the UK or the Isle of Man or is a British citizen. The EPO can act as a receiving office where the applicant is a resident or a national of a State which is a party to both the EPC and the PCT (at present all EPC states are parties to the PCT). For international applications received by the UKIPO or the EPO, the relevant ISA is the EPO.

The UKIPO deals with international applications in the national phase in the same way as a national application, with some modifications. For example, a translation is necessary where the international application was not published in English.

An international application which designates or elects the EPO is equivalent to a normal European application, again with some modifications. For example, where the international application was not published in one of English, French or German, the applicant must supply a translation of the application into one of those languages.

Fees for maintaining a patent covering the UK

Renewal fees are payable on the last day of the month in which the application for the patent was filed, from the fourth anniversary of filing onwards. The fees increase each year, currently from £70 in the fifth year to £600 in each of the twelfth to twentieth years.

The fee for each year should normally be paid within the period of three calendar months ending on the last day of the month in which the renewal date falls. If a renewal fee is not paid within the prescribed period, the patent will lapse. However, if the renewal fee and a late payment fee (currently £24) are paid within six months following the due date, the patent shall be treated as if it had never expired. After the expiry of six months following the due date, at which point the patent has ceased to have effect, the patent can only be restored by making an application to the Comptroller. If the Comptroller is satisfied that the failure to pay the renewal fee (and any late payment fee) was unintentional, he shall restore the patent upon payment.

Supplementary protection certificates

A Supplementary Protection Certificate (SPC) is a form of intellectual property right that extends patent protection in respect of pharmaceutical or plant protection products in qualifying circumstances. An SPC may be granted to the holder of the 'basic patent' (on which see below) or his successor in title.

The SPC regime is based on several key EU Regulations: 469/2009, 1901/2006, 141/2000 (medicinal products); and 1610/96 (plant protection products). However, the legislative regime includes interaction with other EU legislation and UK national law.

Article 3 of both Regulation 469/2009 (medicinal products) and Regulation 1610/96 (plant protection) provides that a certificate shall be granted if, in the Member State in which the application is submitted and at the date of that application:

  1. the product is protected by a basic patent in force;
  2. an appropriate and valid authorisation to place the product on the market has been granted;
  3. the product has not already been the subject of a certificate; and
  4. the authorisation referred to in (b) is the first authorisation to place the product on the market as a medicinal/plant protection product.

A further condition is that the holder of more than one patent for the same product shall not be granted more than one certificate for that product.

These legislative provisions have been interpreted by the Court of Justice of the European Union (CJEU), in decisions which are binding upon the courts in the UK. The case law is complex and the meaning of the above provisions remains the subject of references to the CJEU from the UK High Court. In short, and very simply, the "product" means the active ingredient or combination of active ingredients of a medicinal product; the "medicinal product" means the substance or combination of substances presented for treating or preventing disease (for example the full pharmaceutical formulation); the "basic patent" means a patent which protects a product as such, a process to obtain a product, or an application of a product.

The term of an SPC is intended to compensate, to some degree, for the period elapsing between the filing of an application for a patent and the grant of authorisation to place the relevant product on the market. The duration is equal to the patent life lost between the patent filing date and the date of first marketing authorisation in the EEA (which includes the EU), minus five years, subject to a maximum of five years.

It is possible to extend the SPC for a medicine by six months if certain studies in the paediatric population are carried out, regardless of whether the medicine is ultimately authorised for children.

For EU member states, including the UK, SPCs are granted at the national level by the relevant patent office. For the UK, this entails an application in the prescribed form to the UKIPO, irrespective of whether the basic patent is a national patent (GB) or a European patent designating the UK (EP(UK)). The application fee is currently £250. An application for a paediatric extension must also be in prescribed form and accompanied by a fee of £200.

When all requirements are met, the certificate or extension will be granted. The certificate will state the date of expiry of the maximum possible period of its duration.

The certificate takes effect at the end of the lawful term of the basic patent provided that the basic patent has not previously lapsed or been revoked, and provided the annual fees are paid in time. The annual fees are payable for each year of the effective period of the certificate as a single cumulative amount. It is not possible for an applicant to opt to pay renewal fees one year at a time on an SPC in the UK. Any final period of less than 12 months is treated as a whole year. Currently the fees for five successive years are £600, £1300, £2100, £3000 and £4000. The fees are usually payable on the date on which the certificate is due to take effect and may be paid within the previous three months. Late payment is possible up to six months after the due date subject to an additional fee of one half of the amount of the unpaid fees; the annual fees will then be treated as having been filed on the due date.

If fees are not paid, the certificate will be treated as having lapsed on the date of expiry of the basic patent and so will not take effect.

Rights conferred by a patent covering the UK

The grant of a patent, whether a national patent or a European patent designating the UK, is the grant to the proprietor, for the term of the patent, of a monopoly right in respect of the patented invention.

The scope of the monopoly right conferred by the grant of a patent is defined by the Patents Act: it is limited to acts which infringe the patent pursuant to section 60.

Where the court is satisfied that a third party's acts infringe (or would infringe) the patent, the court will, in the usual course, award relief to remedy the statutory tort of infringement (as discussed in section F below).

The existence of a patent does not entitle the proprietor to relief; it is the order of the court, following a finding of infringement (or threatened infringement) which enables the proprietor of a patent to protect the monopoly conferred by the grant of that patent. Interim relief and other measures (such as disclosure, and seizure) are similarly available only by way of court order, following an application to the court and a conclusion by the court, upon the relevant facts, that such interim relief should be awarded.

Protection against breach of confidence

Know-how and trade secrets may be protected by an obligation of confidentiality arising under the common law or because of specific contractual terms (for example, employment contracts and non-disclosure agreements may include such terms).

Pursuant to the English common law (Coco v Clark (1969) RPC 41; Saltman v Campbell [1963] 3 All ER 413; BBC v HarperCollins [2010] EWHC 2424 (Ch)), it is a tort to use in an unauthorised manner, to the detriment of the originating party, information which has the necessary quality of confidence and is subject to an obligation of confidence. To have the necessary quality of confidence, the information must not be in the public domain or form part of an employee's general skill and knowledge. The requisite obligation of confidence may exist pursuant to a contractual obligation or the circumstances in which it was imparted.

Breach of a contractual term of confidence may also give rise to a claim for breach of contract.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Gowling WLG
Haseltine Lake LLP
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Gowling WLG
Haseltine Lake LLP
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions